(redirected from Abbokinase)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Abbokinase: Streptase


 (yo͝or′ō-kī′nās, -nāz)
An enzyme originally found in human urine that catalyzes the conversion of plasminogen to plasmin and is used in medicine to dissolve blood clots.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


(Biochemistry) a biochemical catalyst present in urine and the blood stream
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014


(ˌyʊər əˈkaɪ neɪs, -neɪz)

an enzyme, present in the blood and urine of mammals, that activates plasminogen and is used medicinally to dissolve blood clots.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.urokinase - protease produced in the kidney that converts plasminogen to plasmin and so initiates fibrinolysis
peptidase, protease, proteinase, proteolytic enzyme - any enzyme that catalyzes the splitting of proteins into smaller peptide fractions and amino acids by a process known as proteolysis
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.


n. urocinasa, enzima presente en la orina que se emplea en la disolución de coágulos.
English-Spanish Medical Dictionary © Farlex 2012


n uroquinasa (INN), urokinasa or urocinasa
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Currently available thrombolytic agents include Alteplase (t-PA or Activase), Reteplase (r-PA or Retavaseurokinase (Abbokinase), prourokinase, Anisoylated Purified Streptokinase Activator Complex (APSAC) and streptokinase 2 are of human origin, which are very expensive.
The thrombolytic drugs tested included: alteplase (Cathflo Activase, Genentech, Inc, San Francisco, California), urokinase (Abbokinase, Abbott Laboratories, Abbott Park, Illinois), streptokinase (Streptase, Aventis, Paris, France), tenecteplase (TNKase, Genentech, Inc), and reteplase (Retavase, Boehringer Mannheim, Mannheim, Germany).
The increase in revenues for each of the periods was primarily the result of the commencement of sales of Abbokinase which accounted for approximately $2.0 million of revenue in the second quarter.